Modulation of tumor angiogenesis by conditional expression of fibroblast growth factor-2 affects early but not established tumors

Cancer Research

Volumn 61, Issue 1, 2001, Pages 309-317

  Giavazzi, Raffaella ^a   Giuliani, Roberta ^b   Coltrini, Daniela ^b   Bani, Maria Rosa ^a   Ferri, Cristina ^a   Sennino, Barbara ^b   Molinari Tosatti, Maria Pia ^b   Stoppacciaro, Antonella ^c   Presta, Marco ^b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; TETRACYCLINE; UROKINASE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER TRANSPLANTATION; CELL MIGRATION; CELL PROLIFERATION; CULTURE MEDIUM; ENDOMETRIUM CARCINOMA; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TUMOR VASCULARIZATION;

ADENOCARCINOMA; ANIMALS; CELL DIVISION; DNA, COMPLEMENTARY; ENDOMETRIAL NEOPLASMS; FEMALE; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; GENETIC VECTORS; HUMANS; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; PROMOTER REGIONS (GENETICS); TETRACYCLINE; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0035132284     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Angiogenesis in cancer, vascular, rheumatoid and other disease
2. The role of the vascular phase in solid tumor growth: A historical review
3. Heparin-affinity: Purification of a tumor-derived capillary endothelial cell growth factor
4. Purification of a factor from human placenta that stimulates capillary endothelial cell protease production. DNA synthesis and migration
5. The heparin-binding (fibroblast) growth factor family of protein
6. The fibroblast growth factors family
7. Biological activities of fibroblast growth factor
8. Purification from a human hepatoma cell line of a basic fibroblast growth factor-like molecule that stimulates capillary endothelial cell plasminogen activator production, DNA synthesis, and migration
9. Angiogenic factors
10. Both normal and tumor cells produce basic fibroblast growth factor
11. bFGF as an autocrine growth factor for human melanomas
12. C6 glioma cells produce basic fibroblast growth factor that can stimulate their own proliferation
13. Enhancement of bFGF export associated with malignant progression of human salivary gland cell clones
14. Basic fibroblast growth factor in human prostate cancer cells
15. In situ detection of basic fibroblast growth factor by highly specific antibodies
16. Immunohistochemical localization of basic fibroblast growth factor in astrocytomas
17. Immunocytochemical localization of basic fibroblast growth factor in carcinomas and inflammatory lesions of the human digestive tract
18. Gene expression of fibroblast growth factors in human gliomas and meningiomas: Demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumor tissues
19. Basic fibroblast growth factor in human pheochromocytoma: A biochemical and immunohistochemical study
20. Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor- 1 in human melanomas blocks intratumoral angiogenesis and tumor growth
21. Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage
22. VEGF-mediated tumor angiogenesis: A new target for cancer therapy
23. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo
24. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence
25. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant
26. Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors
27. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer
28. Basic fibroblast growth factor released by single, isolated cells stimulates their migration in an autocrine manner
29. Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex
30. An autocrine model for cell-associated and matrix-associated fibroblast growth factor
31. In vivo angiogenic activity of urokinase: Role of endogenous fibroblast growth factor-2
32. Increased levels of fibroblast growth factor-like activity in urine from patients with bladder or kidney cancer
33. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers
34. Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumors
35. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma
36. Immunoreactive fibroblast growth factor (FGF) in a transplantable chondrosarcoma: Inhibition of tumor growth by antibodies to FGF
37. Effects of modulation of basic fibroblast growth factor on tumor in vivo
38. Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor
39. A secreted FGF-binding protein can serve as the angiogenic switch in human cancer
40. bFGF and tumor angiogenesis - Back in the limelight?
41. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters
42. Vascular endothelial growth factor is essential for initial but not continued in vivo growth of human breast carcinoma cells
43. A tetracycline-responsive promoter system reveals the role of a secreted binding protein for FGFs during the early phase of tumor growth
44. Growth advantage and vascularization induced by basic fibroblast growth factor overexpression in endometrial HEC-1-B cells: An export-dependent mechanism of action
45. Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette
46. Human basic fibroblast growth factor gene encodes four polypeptides: Three initiate translation from non-AUG codons
47. Bovine endothelial cells transformed in vitro with benzo(a)pyrene
48. Basic fibroblast growth factor overexpression in endothelial cells: An autocrine mechanism for angiogenesis and angioproliferative diseases
49. r24,000 bFGF
50. Internalization of basic fibroblast growth factor (bFGF) in cultured endothelial cells: Role of the low affinity heparin-like bFGF receptors
51. Metastatic behavior of tumor cells isolated from primary and metastatic human colorectal carcinomas implanted into different sites in nude mice
52. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF
53. Quantitative export of FGF-2 occurs through an alternative, energy-dependent, non-ER/Golgi pathway
54. Impact of fibroblast growth factor-2 on tumor microvascular architecture
55. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels
56. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo
57. Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: Novel concepts of angiostatic therapy from intravital video-microscopy
58. Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic metalloproteinase inhibitor
59. A systems approach to cancer therapy
60. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice
61. Vascular channel formation by human melanoma cells in vivo and in vitro
62. Expression of vascular endothelial growth factor induces an invasive phenotype in human squamous cell carcinomas
63. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody
64. Thrombospondin-1 suppresses wound healing and granulation tissue formation in the skin of transgenic mice
65. Thrombospondin-2: A potent endogenous inhibitor of tumor growth and angiogenesis
66. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor
67. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
68. Cancer dormancy: Opportunity for new therapeutic approaches
69. New perspective in clinical oncology from angiogenesis research
70. Angiogenesis research up to 1996. A commentary on the state of art and suggestions for future studies
71. New developments in angiogenesis: A major mechanism for tumor growth and target for therapy